The bile acid-activated phosphatidylinositol 8-kinase pathway inhibits fasapoptosis upstream of bid in rodent hepatocytes

Citation
Y. Takikawa et al., The bile acid-activated phosphatidylinositol 8-kinase pathway inhibits fasapoptosis upstream of bid in rodent hepatocytes, GASTROENTY, 120(7), 2001, pp. 1810-1817
Citations number
35
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
GASTROENTEROLOGY
ISSN journal
00165085 → ACNP
Volume
120
Issue
7
Year of publication
2001
Pages
1810 - 1817
Database
ISI
SICI code
0016-5085(200106)120:7<1810:TBAP8P>2.0.ZU;2-1
Abstract
<(Background & Aims)>: Bile acids differentially modulate hepatocyte injury in cholestasis, Although glycochenode-oxycholate (GCDC) induces Fas-mediat ed hepatocyte apoptosis, taurochenodeoxycholate (TCDC) simultaneously activ ates a phosphatidylinositol 3-kinase (PI 3-K)-mediated survival pathway blo cking Fas apoptosis, In this study, the mechanisms by which the TCDC/PI 3-K survival signal disrupts Fas signaling were examined. (Methods) under bar: Studies were performed in primary cultures of mouse hepatocytes and the bi le-salt-transporting Mc-Ntcp.24 rat hepatoma cell line. (Results) under bar : GCDC, but not TCDC, resulted in cytochrome c release demonstrating that T CDC blocked apoptosis upstream of mitochondria. In contrast, both GCDC and TCDC treatment resulted in Fas aggregation and recruitment of a dominant-ne gative FADD green fluorescent protein (GFP) and C360S pro-caspase 8-GFP to the plasma membrane. Despite recruitment of procaspase 8 to the plasma memb rane by both bile acids, only GCDC resulted in increases of caspase 8 activ ity and Bid-GFP mitochondrial translocation, However, when PI-3K was inhibi ted with wortmannin or dominant-negative PI 3-K, TCDC-induced Bid-GFP mitoc hondrial translocation and cytochrome c release. (Conclusions) under bar: T he TCDC/PI 3-K survival signal blocks Fas-mediated apoptosis by preventing caspase 8 activation and Bid mitochondrial translocation, Potentiation of t his survival pathway in cholestasis has the potential to attenuate liver in jury.